Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Hyperuricemia is a risk factor for the progression to end-stage renal disease in minimal change disease: Su Hyun Song, Tae Ryom Oh, Hong Sang Choi et al.; Kidney Res Clin Pract. 2021;40(3):411-418. Published online September 9, 2021; DOI: https://doi.org/10.23876/j.krcp.20.220
Web of Science 5 Cited By 4; Full text PubReader ePub PDF

Review Articles

Primary glomerulonephritis: A review of important recent discoveries: Jürgen Floege; Kidney Res Clin Pract. 2013;32(3):103-110. Published online July 26, 2013; DOI: https://doi.org/10.1016/j.krcp.2013.06.004
Cited By 10; Full text PubReader PDF

Original Articles

Complete remission induced by tacrolimus and low-dose prednisolone in adult minimal change nephrotic syndrome: A pilot study: Yong Chul Kim, Tae Woo Lee, Hajeong Lee et al.; Kidney Res Clin Pract. 2012;31(2):112-117. Published online May 3, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.04.321
Cited By 6; Full text PubReader PDF

Urinary Angiotensinogen Excretion and Intrarenal Angiotensinogen Expression in Minimal Change Disease Patients: Hye Ryoun Jang, M.D. Ajin Jo, M.D. Ji Hyeon Park, M.D. Jung Eun Lee, M.D. Wooseong Huh, M.D. Dae Joong Kim, M.D. Ha Young Oh, M.D. and Yoon-Goo Kim, M.D.; Korean J Nephrol. 2011;30(6):593-600.; PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

14,494	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,474	C4d Puzzle in ABO-incompatible kidney transplantation
7,863	How should we treat acute kidney injury caused by renal congestion?
12,578	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
34,742	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.